Literature DB >> 5324704

Review of pseudomonas sepsis in thermal burns: verdoglobin determination and gentamicin therapy.

H H Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5324704      PMCID： PMC1477065          DOI： 10.1097/00000658-196602000-00023

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  14 in total

1.  THE MESH SKIN GRAFT.

Authors:  J C TANNER; J VANDEPUT; J F OLLEY
Journal:  Plast Reconstr Surg       Date:  1964-09       Impact factor: 4.730

2.  CHANGING CONCEPTS IN BURN SEPSIS.

Authors:  J A MONCRIEF; C TEPLITZ
Journal:  J Trauma       Date:  1964-03

3.  PSEUDOMONAS VACCINE AND HYPERIMMUNE PLASMA IN THE TREATMENT OF BURNED PATIENTS.

Authors:  I FELLER; I KAMEI
Journal:  Surg Forum       Date:  1964

4.  THE MECHANISM AND TREATMENT OF VERDOGLOBINURIA IN PSEUDOMONAS SEPSIS.

Authors:  H H STONE; J D MARTIN; L KOLB
Journal:  Surg Forum       Date:  1964

5.  GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION.

Authors:  R L JAO; G G JACKSON
Journal:  JAMA       Date:  1964-09-14       Impact factor: 56.272

6.  VERDOGLOBINURIA: AN OMINOUS SIGN OF PSEUDOMONAS SEPTICEMIA IN BURNS.

Authors:  H H STONE; J D MARTIN; C D GRABER
Journal:  Ann Surg       Date:  1964-06       Impact factor: 12.969

7.  IN VITRO SENSITIVITY OF BACTERIAL FLORA FROM BURNED PATIENTS TO GENTAMICIN SULFATE.

Authors:  C D GRABER; H H STONE; L KOLB; J D MARTIN
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

8.  USE OF THE MESH DERMATOME WITH SPLIT-THICKNESS GRAFTS FOR MAJOR BURNS.

Authors:  H H STONE; L W HOBBY
Journal:  Am Surg       Date:  1965-09       Impact factor: 0.688

9.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors:  P V LIU; Y ABE; J L BATES
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

10.  Evaluation of gamma globulin for prophylaxis against burn sepsis.

Authors:  H H Stone; C D Graber; J D Martin; L Kolb
Journal:  Surgery       Date:  1965-11       Impact factor: 3.982
View more
  13 in total

Review 1.  [Effector molecules of the innate immune system for treatment of wound infections].

Authors:  L Steinsträsser; S Langer; M Lehnhardt; H U Steinau
Journal:  Chirurg       Date:  2007-04       Impact factor: 0.955

2.  Kinetics of humoral responsiveness in severe thermal injury.

Authors:  F T Rapaport; R J Bachvaroff
Journal:  Ann Surg       Date:  1976-07       Impact factor: 12.969

3.  Local and systemic therapy of pseudomonas septicemia in burned mice.

Authors:  S M Rosenthal
Journal:  Ann Surg       Date:  1967-01       Impact factor: 12.969

4.  Topical and systemic antibacterial agents in the treatment of burns.

Authors:  R P Hummel; B G MacMillan; W A Altemeier
Journal:  Ann Surg       Date:  1970-09       Impact factor: 12.969

5.  Genetics of natural resistance to thermal injury.

Authors:  F T Rapaport; R J Bachvaroff; J Grullon; H Kunz; T J Gill
Journal:  Ann Surg       Date:  1982-03       Impact factor: 12.969

6.  Topical therapy for control of bacteria in the burn wound.

Authors:  J A Moncrief
Journal:  World J Surg       Date:  1978-03       Impact factor: 3.352

7.  Treatment of burns.

Authors: 
Journal:  Can Med Assoc J       Date:  1967-08-26       Impact factor: 8.262

8.  Respiratory burns: a correlation of clinical and laboratory results.

Authors:  H H Stone; D W Rhame; J D Corbitt; K S Given; J D Martin
Journal:  Ann Surg       Date:  1967-02       Impact factor: 12.969

9.  Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.

Authors:  Lars Steinstraesser; Brian F Tack; Alan J Waring; Teresa Hong; Lee M Boo; Ming-Hui Fan; Daniel I Remick; Grace L Su; Robert I Lehrer; Stewart C Wang
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

10.  Slime of Pseudomonas aeruginosa: in vivo production.

Authors:  G Dimitracopoulos; J W Sensakovic; P F Bartell
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.